Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |